Galunisertib (LY2157299), a transforming growth factor-β receptor I kinase inhibitor, attenuates acute pancreatitis in rats.
about
Galunisertib (LY2157299), a transforming growth factor-β receptor I kinase inhibitor, attenuates acute pancreatitis in rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Galunisertib (LY2157299), a tr ...... es acute pancreatitis in rats.
@en
Galunisertib (LY2157299), a tr ...... es acute pancreatitis in rats.
@nl
type
label
Galunisertib (LY2157299), a tr ...... es acute pancreatitis in rats.
@en
Galunisertib (LY2157299), a tr ...... es acute pancreatitis in rats.
@nl
prefLabel
Galunisertib (LY2157299), a tr ...... es acute pancreatitis in rats.
@en
Galunisertib (LY2157299), a tr ...... es acute pancreatitis in rats.
@nl
P2093
P2860
P1476
Galunisertib (LY2157299), a tr ...... es acute pancreatitis in rats.
@en
P2093
P2860
P356
10.1590/1414-431X20165388
P407
P577
2016-08-01T00:00:00Z